This site uses cookies to store information on your computer. Learn more x

Preliminary Q1 2018 Results

On Thurday 12 April DSM published its preliminary Q1 2018 results.

Feike Sijbesma, DSM's CEO/Chairman, commented “We are very pleased that the strong underlying performance of our business continues, with growth well above market. In addition, we are currently benefitting from substantially higher prices in some vitamins due to exceptional supply disruptions in the industry, which are expected to be temporary and heavily weighted towards the first half of the year. These two combined result in a significantly higher outlook for the full year 2018.” More >

Share price and volume

Share price> € 0.0 0.0%

More share info >